vs
Information Services Group Inc.（III）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Information Services Group Inc.的1.2倍（$75.5M vs $61.2M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 5.9%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $4.3M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -2.4%）
EBSCO信息服务总部位于马萨诸塞州伊普斯威奇，隶属于总部设在阿拉巴马州伯明翰的私营企业EBSCO工业集团。该企业面向全球各类图书馆提供信息产品与服务，核心产品包含全流程电子资源管理系统EBSCONET，以及付费在线研究服务平台EBSCOhost，平台拥有375个全文数据库与超60万册电子书资源。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
III vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.2倍
$61.2M
营收增速更快
PBYI
高出21.8%
5.9%
自由现金流更多
PBYI
多$10.1M
$4.3M
两年增速更快
PBYI
近两年复合增速
-2.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $61.2M | $75.5M |
| 净利润 | $2.6M | — |
| 毛利率 | 44.8% | 69.3% |
| 营业利润率 | 8.4% | 22.7% |
| 净利率 | 4.3% | — |
| 营收同比 | 5.9% | 27.7% |
| 净利润同比 | -14.1% | — |
| 每股收益（稀释后） | $0.06 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IIIPBYI
| Q4 25 | $61.2M | $75.5M | ||
| Q3 25 | $62.4M | $54.5M | ||
| Q2 25 | $61.6M | $52.4M | ||
| Q1 25 | $59.6M | $46.0M | ||
| Q4 24 | $57.8M | $59.1M | ||
| Q3 24 | $61.3M | $80.5M | ||
| Q2 24 | $64.3M | $47.1M | ||
| Q1 24 | $64.3M | $43.8M |
净利润IIIPBYI
| Q4 25 | $2.6M | — | ||
| Q3 25 | $3.1M | $8.8M | ||
| Q2 25 | $2.2M | $5.9M | ||
| Q1 25 | $1.5M | $3.0M | ||
| Q4 24 | $3.0M | — | ||
| Q3 24 | $1.1M | $20.3M | ||
| Q2 24 | $2.0M | $-4.5M | ||
| Q1 24 | $-3.4M | $-4.8M |
毛利率IIIPBYI
| Q4 25 | 44.8% | 69.3% | ||
| Q3 25 | 42.2% | 77.7% | ||
| Q2 25 | 42.2% | 76.5% | ||
| Q1 25 | 43.1% | 77.1% | ||
| Q4 24 | 41.5% | 76.4% | ||
| Q3 24 | 40.4% | 63.9% | ||
| Q2 24 | 39.5% | 77.4% | ||
| Q1 24 | 36.1% | 75.5% |
营业利润率IIIPBYI
| Q4 25 | 8.4% | 22.7% | ||
| Q3 25 | 7.4% | 17.6% | ||
| Q2 25 | 7.6% | 12.7% | ||
| Q1 25 | 5.7% | 8.7% | ||
| Q4 24 | 0.3% | 22.6% | ||
| Q3 24 | 7.0% | 27.4% | ||
| Q2 24 | 5.7% | -4.6% | ||
| Q1 24 | -3.7% | -5.3% |
净利率IIIPBYI
| Q4 25 | 4.3% | — | ||
| Q3 25 | 4.9% | 16.2% | ||
| Q2 25 | 3.5% | 11.2% | ||
| Q1 25 | 2.5% | 6.5% | ||
| Q4 24 | 5.3% | — | ||
| Q3 24 | 1.9% | 25.2% | ||
| Q2 24 | 3.2% | -9.6% | ||
| Q1 24 | -5.3% | -11.0% |
每股收益（稀释后）IIIPBYI
| Q4 25 | $0.06 | $0.26 | ||
| Q3 25 | $0.06 | $0.17 | ||
| Q2 25 | $0.04 | $0.12 | ||
| Q1 25 | $0.03 | $0.06 | ||
| Q4 24 | $0.07 | $0.40 | ||
| Q3 24 | $0.02 | $0.41 | ||
| Q2 24 | $0.04 | $-0.09 | ||
| Q1 24 | $-0.07 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $28.7M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $94.7M | $130.3M |
| 总资产 | $211.0M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资IIIPBYI
| Q4 25 | $28.7M | $97.5M | ||
| Q3 25 | $28.7M | $94.4M | ||
| Q2 25 | $25.2M | $96.0M | ||
| Q1 25 | $20.1M | $93.2M | ||
| Q4 24 | $23.1M | $101.0M | ||
| Q3 24 | $9.7M | $96.7M | ||
| Q2 24 | $11.8M | $96.8M | ||
| Q1 24 | $14.0M | $107.2M |
总债务IIIPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益IIIPBYI
| Q4 25 | $94.7M | $130.3M | ||
| Q3 25 | $94.7M | $115.3M | ||
| Q2 25 | $94.1M | $104.7M | ||
| Q1 25 | $95.0M | $97.1M | ||
| Q4 24 | $96.3M | $92.1M | ||
| Q3 24 | $96.6M | $71.1M | ||
| Q2 24 | $95.5M | $48.5M | ||
| Q1 24 | $95.6M | $51.0M |
总资产IIIPBYI
| Q4 25 | $211.0M | $216.3M | ||
| Q3 25 | $213.3M | $202.9M | ||
| Q2 25 | $200.7M | $194.9M | ||
| Q1 25 | $202.4M | $196.2M | ||
| Q4 24 | $204.5M | $213.3M | ||
| Q3 24 | $227.1M | $220.7M | ||
| Q2 24 | $235.3M | $205.0M | ||
| Q1 24 | $234.2M | $214.1M |
负债/权益比IIIPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.1M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $4.3M | $14.4M |
| 自由现金流率自由现金流/营收 | 7.0% | 19.1% |
| 资本支出强度资本支出/营收 | 1.2% | 0.0% |
| 现金转化率经营现金流/净利润 | 1.94× | — |
| 过去12个月自由现金流最近4个季度 | $25.0M | $41.7M |
8季度趋势，按日历期对齐
经营现金流IIIPBYI
| Q4 25 | $5.1M | $14.4M | ||
| Q3 25 | $11.1M | $9.7M | ||
| Q2 25 | $11.9M | $14.1M | ||
| Q1 25 | $978.0K | $3.6M | ||
| Q4 24 | $6.6M | $15.6M | ||
| Q3 24 | $8.8M | $11.0M | ||
| Q2 24 | $2.2M | $1.0M | ||
| Q1 24 | $2.3M | $11.2M |
自由现金流IIIPBYI
| Q4 25 | $4.3M | $14.4M | ||
| Q3 25 | $9.5M | $9.7M | ||
| Q2 25 | $11.1M | $14.1M | ||
| Q1 25 | $141.0K | $3.6M | ||
| Q4 24 | $6.0M | $15.6M | ||
| Q3 24 | $8.4M | $11.0M | ||
| Q2 24 | $1.3M | $1.0M | ||
| Q1 24 | $1.3M | — |
自由现金流率IIIPBYI
| Q4 25 | 7.0% | 19.1% | ||
| Q3 25 | 15.2% | 17.7% | ||
| Q2 25 | 18.0% | 26.8% | ||
| Q1 25 | 0.2% | 7.7% | ||
| Q4 24 | 10.4% | 26.4% | ||
| Q3 24 | 13.7% | 13.7% | ||
| Q2 24 | 2.0% | 2.1% | ||
| Q1 24 | 2.0% | — |
资本支出强度IIIPBYI
| Q4 25 | 1.2% | 0.0% | ||
| Q3 25 | 2.5% | 0.0% | ||
| Q2 25 | 1.4% | 0.0% | ||
| Q1 25 | 1.4% | 0.1% | ||
| Q4 24 | 0.9% | 0.0% | ||
| Q3 24 | 0.6% | 0.0% | ||
| Q2 24 | 1.4% | 0.0% | ||
| Q1 24 | 1.6% | 0.0% |
现金转化率IIIPBYI
| Q4 25 | 1.94× | — | ||
| Q3 25 | 3.62× | 1.10× | ||
| Q2 25 | 5.46× | 2.41× | ||
| Q1 25 | 0.66× | 1.21× | ||
| Q4 24 | 2.15× | — | ||
| Q3 24 | 7.66× | 0.54× | ||
| Q2 24 | 1.07× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
